Evidence map›Paper›PMID 28659829›Full record

ArticleFrontiers in psychiatry2017

Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia.

Juan R Bustillo, Veena Patel, Thomas Jones, Rex Jung, Nattida Payaknait, Clifford Qualls, Jose M Canive, Jingyu Liu, Nora Irma Perrone-Bizzozero, Vince D Calhoun and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: aNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Juan R BustilloDepartment of Psychiatry, University of New Mexico, Albuquerque, NM, United States.
Veena PatelMind Research Network, Albuquerque, NM, United States.
Thomas JonesDepartment of Psychiatry, University of New Mexico, Albuquerque, NM, United States.
Rex JungDepartment of Neurosurgery, University of New Mexico, Albuquerque, NM, United States.
Nattida PayaknaitDepartment of Psychiatry, University of New Mexico, Albuquerque, NM, United States.
Clifford QuallsDepartment of Mathematics and Statistics, University of New Mexico, Albuquerque, NM, United States.
Jose M CaniveDepartment of Psychiatry, University of New Mexico, Albuquerque, NM, United States.
Jingyu LiuMind Research Network, Albuquerque, NM, United States.
Nora Irma Perrone-BizzozeroDepartment of Psychiatry, University of New Mexico, Albuquerque, NM, United States.
Vince D CalhounDepartment of Psychiatry, University of New Mexico, Albuquerque, NM, United States.
Jessica A TurnerMind Research Network, Albuquerque, NM, United States.
Charles GasparovicMind Research Network, Albuquerque, NM, United States.
University of New Mexico · USMind Research Network · USNew Mexico VA Health Care System · US

Funding

Transcranial Direct Current Stimulation for Treatment of Auditory Verbal HalluciP20GM103472 · NIGMS · THE MIND RESEARCH NETWORK · PI ABBOTT, CHRISTOPHER C · 2012 to 2017
$14.3M
Multivariate methods for identifying multitask/multimodal brain imaging biomarkersR01EB006841 · NIBIB · THE MIND RESEARCH NETWORK · PI VINCE D CALHOUN, Sergey Plis · 2007 to 2026
$9.8M
NEURAL MECHANISMS OF SCHIZOPHRENIAP20RR021938 · NCRR · THE MIND RESEARCH NETWORK · PI JUNG, REX · 2008 to 2011
$9.4M
UNIVERSITY OF NEW MEXICO CLINICAL AND TRANSLATIONAL SCIENCE CENTERUL1RR031977 · NCRR · UNIVERSITY OF NEW MEXICO · PI LARSON, RICHARD S · 2010 to 2011
$8.8M
Schizophrenia Gating Deficit Mechanisms: Extending the CircuitR01MH065304 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CANIVE, JOSE MIGUEL · 2002 to 2013
$3.7M
Brain Glutamate and Outcome in SchizophreniaR01MH084898 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BUSTILLO, JUAN RICARDO · 2009 to 2013
$1.7M
NCRR NIH HHS P20 RR021938NCRR NIH HHS UL1 RR031977NIBIB NIH HHS R01 EB006841NIGMS NIH HHS P20 GM103472NIMH NIH HHS R01 MH065304NIMH NIH HHS R01 MH084898
6 · The paper itself

Abstract

backgroundThe proton magnetic resonance spectroscopy (

methods

resultsGlx levels in GM positively correlated with glutamate-related genetic risk score but only in younger (≤36 years) schizophrenia patients (

conclusionElevations in brain Glx are in part, related to common allelic variants of glutamate-related genes known to increase the risk for schizophrenia. Since the glutamate risk scores did not differ between groups, some other genetic or environmental factors likely interact with the variability in glutamate-related risk SNPs to contribute to an increase in brain Glx early in the illness.

Indexed as

geneticsglutamateschizophreniasingle-nucleotide polymorphismsspectroscopy

Identifiers

PMID28659829
PMCPMC5466972
OpenAlexW2622355154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.